3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Sunitinib
4
Surgical Procedures, Operative
2
Laparoscopy
2
Dasatinib
2
Biopsy, Fine-Needle
2
ripretinib
1
motexafin lutetium
1
apatinib
1
Thoracic Surgery, Video-Assisted
1
Surveys and Questionnaires
1
Surgical Instruments
1
Quality of Life
1
Psychiatric Rehabilitation
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Liver Transplantation
1
Indocyanine Green
1
Imatinib Mesylate
1
Fluorescein
1
Endoscopic Mucosal Resection
1
Early Intervention, Educational
1
Cytological Techniques
1
Counseling
1
Clobetasol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Gastrointestinal Stromal Tumors
×
Poly(ADP-ribose) Polymerase Inhibitors
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled